NCT02639273View on ClinicalTrials.gov

Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene Variation

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 8, 2016

Primary Completion Date

December 8, 2023

Study Completion Date

December 8, 2023

Conditions

AUD

Interventions

DRUG

Nalmefene

Active Drug

OTHER

Placebo

Single Dose Placebo

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

NCT02639273 - Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene Variation | Biotech Hunter | Biotech Hunter